osimertinib,tepotinib
astrazeneca,merck
['lcsm,(-blcsm)', 'osimertinib', 'insight 2', 'nsclc', 'sclc', 'tepotinib']
tepotinib + osimertinib for egfrm
nsclc with met amplification
(metamp) after progression on first-
line (1l) osimertinib: initial results from
the insight 2 study. orr 50% time for a rct vs chemo? #esmo22 #lcsm 
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm